Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Gel Manufacturing: SOP for Labeling and Quarantine of Bulk Gel Batches – V 2.0

Posted on By

Gel Manufacturing: SOP for Labeling and Quarantine of Bulk Gel Batches – V 2.0

Standard Operating Procedure for Labeling and Quarantine of Bulk Gel Batches


Department Gel Manufacturing
SOP No. SOP/GM/040/2025
Supersedes SOP/GM/040/2022
Page No. Page 1 of 10
Issue Date 02/06/2025
Effective Date 04/06/2025
Review Date 02/06/2026

1. Purpose

To define the procedure for proper labeling and quarantine of bulk gel batches post-manufacture and prior to quality clearance for filling and packaging, in compliance with GMP and regulatory guidelines.

2. Scope

This procedure is applicable to all bulk gel batches manufactured in the Gel

Manufacturing Department of the pharmaceutical formulation facility.

3. Responsibilities

  • Production Officer: Ensures proper labeling and physical transfer to the quarantine area.
  • Quality Assurance (QA): Ensures compliance with labeling standards and authorizes movement out of quarantine.
  • Warehouse Staff: Manages space and environmental controls in the quarantine area.
See also  Gel Manufacturing: SOP for Labeling Machines for Gel Packaging - V 2.0

4. Accountability

The Head – Manufacturing is accountable for the effective implementation of this SOP and ensuring adherence during audits.

5. Procedure

5.1 Label Preparation and Information

  1. After the completion of bulk manufacturing, prepare the quarantine label as per format provided in Annexure-1.
  2. Label must include the following information:
    • Product Name
    • Batch Number
    • Manufacturing Date
    • Storage Conditions
    • Quantity
    • Status: “Quarantine”
  3. Label should be printed or handwritten legibly using indelible ink.

5.2 Label Application

  1. Affix the label securely on the container body (not lid) to ensure it remains visible during handling.
  2. Use weather-resistant adhesive labels for stainless steel tanks or high-density plastic containers.
  3. Place an additional tag with batch number on the tank handle using a cable tie.

5.3 Quarantine Transfer

  1. Transfer the labeled container to the designated quarantine area in the warehouse or manufacturing block.
  2. Maintain an updated entry in the Quarantine Storage Log – Annexure-2.
  3. Ensure storage under specified conditions (temperature, humidity) as mentioned in the label.
See also  Gel Manufacturing: SOP for Identifying Degradation Products in Gels - V 2.0

5.4 Quarantine Area Management

  1. Quarantine area must be clearly demarcated with access restricted to authorized personnel only.
  2. Install signage such as “QUARANTINE AREA – NO UNAUTHORIZED ACCESS”.
  3. Environmental monitoring should be conducted and recorded daily.

5.5 Release or Rejection

  1. QA will review the batch documents and sampling results.
  2. If compliant, QA will replace the “Quarantine” label with “Approved for Use” status tag.
  3. In case of rejection, affix “Rejected” tag and initiate deviation investigation as per applicable SOP.

6. Abbreviations

  • QA: Quality Assurance
  • GMP: Good Manufacturing Practice
  • SOP: Standard Operating Procedure

7. Documents

  1. Quarantine Label Template – Annexure-1
  2. Quarantine Storage Log – Annexure-2
  3. Batch Manufacturing Record (BMR)
See also  Gel Manufacturing: SOP for Handling Stability Failures in Gels - V 2.0

8. References

  • Schedule M Guidelines for Quarantine Management
  • WHO GMP Guidelines for Storage and Distribution

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Jr. Production Chemist QA Executive Head – Manufacturing
Department Gel Manufacturing Quality Assurance Manufacturing

11. Annexures

Annexure-1: Quarantine Label Template

This label should contain: Product Name, Batch No., Mfg. Date, Quantity, Storage Conditions, Status (“Quarantine”).

Annexure-2: Quarantine Storage Log

Details to include: Container ID, Product Name, Batch No., Date In, Date Out, Storage Location, Verified By QA.

Revision History:

Revision Date Revision No. Details Reason Approved By
01/05/2022 1.0 Initial SOP release New procedure QA Head
02/06/2025 2.0 Added dual label system and annexure log Process clarity QA Head
Gels V 2.0 Tags:gel excipients SOP, gel extrudability SOP, gel formulation process guidelines, gel formulation safety SOP, gel formulation SOP template, gel homogenization SOP, gel ingredient weighing SOP, gel labeling and documentation SOP, gel microbial contamination SOP, gel packaging SOP, gel viscosity measurement SOP, gel viscosity testing SOP, pharmaceutical gel SOP, quality control SOP gel formulations, SOP for carbopol gel formulation, SOP for gel pH adjustment, SOP for gel spreadability test, stability testing SOP gel, standard operating procedure gel preparation, topical gel manufacturing SOP

Post navigation

Previous Post: BA-BE Studies: SOP for Sample Thawing and Equilibration – V 2.0
Next Post: Creams: SOP for Calibration of Viscometers for Cream Testing – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version